Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Cysteamine (Cystagon®) adherence in patients with cystinosis in Spain: successful in children and a challenge in adolescents and adults.

Ariceta G, Lara E, Camacho JA, Oppenheimer F, Vara J, Santos F, Muñoz MA, Cantarell C, Gil Calvo M, Romero R, Valenciano B, García-Nieto V, Sanahuja MJ, Crespo J, Justa ML, Urisarri A, Bedoya R, Bueno A, Daza A, Bravo J, Llamas F, Jiménez Del Cerro LA.

Nephrol Dial Transplant. 2015 Mar;30(3):475-80. doi: 10.1093/ndt/gfu329. Epub 2014 Oct 26.

2.

Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.

Nesterova G, Williams C, Bernardini I, Gahl WA.

Pediatr Nephrol. 2015 Jun;30(6):945-51. doi: 10.1007/s00467-014-3018-x. Epub 2014 Dec 20.

PMID:
25526929
3.

Mood and illness experiences of adults with cystinosis.

Beinart N, Hackett RA, Graham CD, Weinman J, Ostermann M.

Ren Fail. 2015 Jun;37(5):835-9. doi: 10.3109/0886022X.2015.1015391. Epub 2015 Feb 26.

PMID:
25715639
4.

Recent advances in the treatment of cystinosis.

Schneider JA, Clark KF, Greene AA, Reisch JS, Markello TC, Gahl WA, Thoene JG, Noonan PK, Berry KA.

J Inherit Metab Dis. 1995;18(4):387-97. Review.

5.

Halitosis in cystinosis patients after administration of immediate-release cysteamine bitartrate compared to delayed-release cysteamine bitartrate.

Besouw M, Tangerman A, Cornelissen E, Rioux P, Levtchenko E.

Mol Genet Metab. 2012 Sep;107(1-2):234-6. doi: 10.1016/j.ymgme.2012.06.017. Epub 2012 Jul 6.

PMID:
22832073
6.

Switching from immediate- to extended-release cysteamine in nephropathic cystinosis patients: a retrospective real-life single-center study.

Ahlenstiel-Grunow T, Kanzelmeyer NK, Froede K, Kreuzer M, Drube J, Lerch C, Pape L.

Pediatr Nephrol. 2017 Jan;32(1):91-97. Epub 2016 Jun 27.

PMID:
27350621
7.

Cystinosis: a new perspective.

Veys KR, Besouw MT, Pinxten AM, Dyck MV, Casteels I, Levtchenko EN.

Acta Clin Belg. 2016 Jun;71(3):131-7. doi: 10.1179/2295333714Y.0000000113. Review.

PMID:
25560059
8.

Cystinosis in adult and adolescent patients: Recommendations for the comprehensive care of cystinosis.

Ariceta G, Camacho JA, Fernández-Obispo M, Fernández-Polo A, Gamez J, García-Villoria J, Lara Monteczuma E, Leyes P, Martín-Begué N, Oppenheimer F, Perelló M, Morell GP, Torra R, Santandreu AV, Güell A; Grupo T-CiS.bcn.

Nefrologia. 2015;35(3):304-21. English, Spanish.

9.

A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety.

Langman CB, Greenbaum LA, Sarwal M, Grimm P, Niaudet P, Deschênes G, Cornelissen E, Morin D, Cochat P, Matossian D, Gaillard S, Bagger MJ, Rioux P.

Clin J Am Soc Nephrol. 2012 Jul;7(7):1112-20. doi: 10.2215/CJN.12321211. Epub 2012 May 3. Erratum in: Clin J Am Soc Nephrol. 2013 Mar 7;8(3):468.

10.

[Cystinosis in adults: A systemic disease].

Servais A, Goizet C, Bertholet-Thomas A, Decramer S, Llanas B, Choukroun G, Novo R.

Nephrol Ther. 2015 Jun;11(3):152-9. doi: 10.1016/j.nephro.2014.12.001. Epub 2015 Mar 11. Review. French.

PMID:
25769364
11.

[Intra-leukocyte cystine in cystinosis treated with cysteamine].

Ged C, Jean G, Tete MJ, Broyer M, Kamoun P.

Ann Biol Clin (Paris). 1991;49(9):482-6. French.

PMID:
1789502
12.

Efficacy of topical cysteamine in nephropathic cystinosis.

Al-Hemidan A, Shoughy SS, Kozak I, Tabbara KF.

Br J Ophthalmol. 2017 Sep;101(9):1234-1237. doi: 10.1136/bjophthalmol-2016-309278. Epub 2017 Jan 5.

PMID:
28057644
13.

Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.

Brodin-Sartorius A, Tête MJ, Niaudet P, Antignac C, Guest G, Ottolenghi C, Charbit M, Moyse D, Legendre C, Lesavre P, Cochat P, Servais A.

Kidney Int. 2012 Jan;81(2):179-89. doi: 10.1038/ki.2011.277. Epub 2011 Sep 7.

14.

Nephropathic cystinosis in children: An overlooked disease.

Soliman NA, El-Baroudy R, Rizk A, Bazaraa H, Younan A.

Saudi J Kidney Dis Transpl. 2009 May;20(3):436-42.

15.

N-acetyl-cysteine is associated to renal function improvement in patients with nephropathic cystinosis.

Pache de Faria Guimaraes L, Seguro AC, Shimizu MH, Lopes Neri LA, Sumita NM, de Bragança AC, Aparecido Volpini R, Cunha Sanches TR, Macaferri da Fonseca FA, Moreira Filho CA, Vaisbich MH.

Pediatr Nephrol. 2014 Jun;29(6):1097-102. doi: 10.1007/s00467-013-2705-3. Epub 2013 Dec 11.

PMID:
24326786
16.

[Peculiarity of infantile cystinosis in Tunisian children].

Jellouli M, Ben Turkia H, Abidi K, Hammi Y, Gargah T.

Pan Afr Med J. 2015 Dec 11;22:348. doi: 10.11604/pamj.2015.22.348.7727. eCollection 2015. French. No abstract available.

17.

Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Langman CB, Barshop BA, Deschênes G, Emma F, Goodyer P, Lipkin G, Midgley JP, Ottolenghi C, Servais A, Soliman NA, Thoene JG, Levtchenko EN; Conference Participants.

Kidney Int. 2016 Jun;89(6):1192-203. doi: 10.1016/j.kint.2016.01.033.

PMID:
27181776
18.

[Treatment of cystinosis using cysteamine].

Broyer M, Tete MJ.

Ann Pediatr (Paris). 1990 Feb;37(2):91-3. French.

PMID:
2321906
19.

Cysteamine in renal transplantation: A report of two patients with nephropathic cystinosis and the successful re-initiation of cysteamine therapy during the immediate post-transplant period.

Berryhill A, Bhamre S, Chaudhuri A, Concepcion W, Grimm PC.

Pediatr Transplant. 2016 Feb;20(1):141-5. doi: 10.1111/petr.12617. Epub 2015 Oct 19.

PMID:
26477696
20.

Long-term treatment of cystinosis in children with twice-daily cysteamine.

Dohil R, Gangoiti JA, Cabrera BL, Fidler M, Schneider JA, Barshop BA.

J Pediatr. 2010 May;156(5):823-7. doi: 10.1016/j.jpeds.2009.11.059. Epub 2010 Feb 6.

PMID:
20138296

Supplemental Content

Support Center